Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer ; volume:13 ; number:1 ; day:28 ; month:1 ; year:2011 ; pages:1-15 ; date:2.2011
Breast cancer research ; 13, Heft 1 (28.1.2011), 1-15, 2.2011
- Urheber
-
Arendt, Lisa M.
- Beteiligte Personen und Organisationen
-
Rugowski, Debra E.
Grafwallner-Huseth, Tara A.
Garcia-Barchino, Maria Jose
Rui, Hallgeir
Schuler, Linda A.
SpringerLink (Online service)
- DOI
-
10.1186/bcr2819
- URN
-
urn:nbn:de:1111-2016032411416
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Arendt, Lisa M.
- Rugowski, Debra E.
- Grafwallner-Huseth, Tara A.
- Garcia-Barchino, Maria Jose
- Rui, Hallgeir
- Schuler, Linda A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas
Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas
Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas
MRI features of breast cancer immunophenotypes with a focus on luminal estrogen receptor low positive invasive carcinomas
Androgen receptor and FOXA1 coexpression define a “luminal-AR” subtype of feline mammary carcinomas, spontaneous models of breast cancer
Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells
Multipotent luminal mammary cancer stem cells model tumor heterogeneity
Estrogen receptors genotypes and canine mammary neoplasia
Cancer-associated fibroblasts rewire the estrogen receptor response in luminal breast cancer, enabling estrogen independence
Estrogen-induced immune changes within the normal mammary gland
VANGL2 regulates luminal epithelial organization and cell turnover in the mammary gland
The role of Sox9 in mouse mammary gland development and maintenance of mammary stem and luminal progenitor cells
STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas
Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas
Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas
MRI features of breast cancer immunophenotypes with a focus on luminal estrogen receptor low positive invasive carcinomas
Androgen receptor and FOXA1 coexpression define a “luminal-AR” subtype of feline mammary carcinomas, spontaneous models of breast cancer
Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells
Multipotent luminal mammary cancer stem cells model tumor heterogeneity
Estrogen receptors genotypes and canine mammary neoplasia
Cancer-associated fibroblasts rewire the estrogen receptor response in luminal breast cancer, enabling estrogen independence
Estrogen-induced immune changes within the normal mammary gland
VANGL2 regulates luminal epithelial organization and cell turnover in the mammary gland
The role of Sox9 in mouse mammary gland development and maintenance of mammary stem and luminal progenitor cells
STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas
Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas
Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas
MRI features of breast cancer immunophenotypes with a focus on luminal estrogen receptor low positive invasive carcinomas
Androgen receptor and FOXA1 coexpression define a “luminal-AR” subtype of feline mammary carcinomas, spontaneous models of breast cancer
Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells
Multipotent luminal mammary cancer stem cells model tumor heterogeneity
Estrogen receptors genotypes and canine mammary neoplasia
Cancer-associated fibroblasts rewire the estrogen receptor response in luminal breast cancer, enabling estrogen independence
Estrogen-induced immune changes within the normal mammary gland
VANGL2 regulates luminal epithelial organization and cell turnover in the mammary gland